Eli Lilly partners with Oura to support GLP-1 patients via smart‑ring tools

Eli Lilly's LillyDirect has entered a collaboration with Oura, the maker of the Oura Ring, to support patients using GLP-1 medications such as Zepbound and Mounjaro

As part of the partnership, eligible LillyDirect customers can request a complimentary Oura Ring sizing kit, lowering the barrier to using the smart ring

The collaboration does not involve sharing of user data between Eli Lilly and Oura; it is a marketing and support initiative rather than a technical integration

Oura recently launched GLP-1 Insights, an in‑app feature that helps GLP-1 users track doses, side effects, and weight, while providing reminders to take medication

The initiative is designed to help patients build healthier, sustainable habits around sleep, activity, and recovery, complementing their prescribed GLP‑1 therapy and improving long‑term adherence

Sources:

ŌURA and LillyDirect to Expand Support for People Using ...

Oura is teaming up with Eli Lilly's LillyDirect to help GLP ...

Eli Lilly Collaborates with ŌURA on GLP-1 Therapy Support - LinkedIn

Lilly Partners with ŌURA for GLP-1 Tracking

Ricky Bloomfield's Post - LinkedIn

Eli Lilly's ŌURA Partnership Drives Longitudinal Patient ...

Oura Partners with Eli Lilly to Track GLP-1 Drug Users' Health — Smart Rings Enter the Pharma Ecosystem

Why Eli Lilly is collaborating with Oura

Eli Lilly reports additional data on weight-loss pill from diabetes trial